Delivery Order SPE2DB24D1104-SPE2DB25FXZE2
Award Date
3/26/25
Potential Completion Date
3/27/25
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order worth $34,232.81 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Firm Fixed Price contract, which has an ultimate completion date of December 20, 2024, is for the delivery of 4566771042 - PROLIA 60 MG/ML SYRINGEML. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,462.50 firm fixed-price delivery order is for the supply of PROLIA 60 MG/ML syringes. The contract has an ultimate completion date of March 21, 2025 and was awarded on March 20, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,733.97, is a Firm Fixed Price Delivery Order for the supply of PROLIA 60 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of November 5, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
The U.S. Defense Logistics Agency (DLA) awarded a $5,228.20 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the procurement of PROLIA 60 MG/ML syringe, a specialty pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to procure Prolia 60 mg/ml syringes. The contract has a ceiling value of $12,857.40 and an ultimate completion date of March 12, 2025. This contract award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,797.47 firm fixed-price delivery order is for the supply of PROLIA 60 MG/ML syringes. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of PROLIA 60 MG/ML syringes, awarded to the prime contractor AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA). The contract has a total ceiling value of $42,850.78 and runs through December 16, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award, valued at $22,873.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROLIA 60 MG/ML SYRINGEML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,763.88 firm fixed-price contract is for the supply of PROLIA 60 MG/ML syringes. The award does not have a set-aside designation, indicating open competition. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,403.56 firm fixed-price delivery order contract is for the supply of Prolia 60 mg/ml syringes. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...